Plasma prostaglandin F 2-alpha levels in dysmenorrehic women

M M Shangold, Mona M. Shangold, Sezer Aksel, S Aksel, David W. Schomberg, D W Schomberg, Charles B. Hammond, C B Hammond
Fertility and sterility · 1976 · vol. 27(10) , pp. 1171–1175 · doi:10.1016/s0015-0282(16)42135-7 · PMID:971774 · W2495037009
Other OA: closed CC0 ⤵ 4 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This paper investigated prostaglandin F2 levels in the plasma of women experiencing dysmenorrhea.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Plasma prostaglandin F 2-alpha (PGF 2-alpha) concentrations were compared in nine ovulatory dysmenorrheic women, one dysmenorrheic oral contraceptive user, and two nondysmenorrheic control subjects, in an effort to demonstrate a relationship between plasma PGF 2-alpha levels and dysmenorrhea. In addition, the effects of aspirin, a known inhibitorof prostaglandins synthesis, on dysmenorrhea and on PGF 2-alpha levels were investigated. No statistical difference was demonstrated between the plasma PGF 2-alpha levels of dysmenorrheic and nondysmenorrheic subjects throughout the menstrual cycle. Attainment of an adequate salicylate level was accompanied by a significant decrease in PGF 2-alpha levels. All dysmenorrheic subjects reported improvement in symptoms while taking aspirin. The greatest subjective relief was reported by women who began taking aspirin (10 grains every 4 hours) 3 or more days prior to the onset of bleeding.

My notes (saved in your browser only)

MeSH descriptors

Aspirin Dysmenorrhea Prostaglandins F Adult Aspirin Aspirin Dysmenorrhea Dysmenorrhea Female Humans Luteinizing Hormone Luteinizing Hormone Menstruation Progestins Progestins Prostaglandins F

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Cited by (3)

References (10)

Cited by (3)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T22:00:41.816812+00:00
unpaywall
last seen: 2026-10-11T06:28:45.473802+00:00
License: CC0 · commercial use OK